Molina and its top executives didn’t tell investors about a mismatch between its premium rates and medical cost trends, or that short-term growth relied on patients not using “behavioral health, pharmacy, and inpatient and outpatient services,” according to the complaint filed in the US District Court for the Central District of California on Oct. 3.
Investor Jeffrey Hindlemann filed the proposed class action seeking damages for alleged ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.